(9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one and Dermatomycoses

Topics: Administration, Cutaneous; Adolescent; Adult; Antifungal Agents; Beclomethasone; Clotrimazole; Dermatomycoses; Drug Administration Schedule; Drug Combinations; Humans; Male; Middle Aged; Treatment Outcome

Forty patients with skin diseases were treated by the simultaneous application of three creams, the respective bases of which were beclomethasone dipropionate, sodium fusidate and ketoconazole. The treatment yielded positive results in 92.5% of the treated cases with good relief of symptoms, arrest of growth of pathogenic agents, and good local and systemic tolerance. No adverse reactions of any kind were observed.

Topics: Administration, Topical; Adolescent; Adult; Aged; Bacterial Infections; Beclomethasone; Child; Dermatitis, Contact; Dermatomycoses; Drug Combinations; Female; Fusidic Acid; Humans; Ketoconazole; Male; Middle Aged; Skin Diseases; Skin Diseases, Infectious

Forty-two infants and young children with skin diseases of various kinds were treated by the simultaneous application of a combination of three creams, the respective ingredients of which were beclomethasone dipropionate, sodium fusidate and ketoconazole. The treatment produced good results in 97.6% of cases, with eradication of pathogenic agents and satisfactory relief of symptoms. The combination was well tolerated in almost all cases, both locally and systemically, and no adverse reactions were reported.

Topics: Administration, Topical; Bacterial Infections; Beclomethasone; Child; Child, Preschool; Dermatomycoses; Diaper Rash; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Infant; Ketoconazole; Male; Skin Diseases